Moreover, one of the well-established dose-limiting toxicities associated with docetaxel chemotherapy in breast cancer patients is fatigue [47], and high TNF levels have been shown to correlate with fatigue onset in cancer patients [48]. The gene discussed is TNF; the disease is breast cancer.